US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class III · Low risk Terminated

ENALAPRIL MALEATE Tablets

Reason Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.

Aidarex Pharmaceuticals LLC NDC 33261-0693-90 D-0053-2018
Class II · Moderate risk Terminated

Sterile Water for Injection

Reason Non-Sterility: cracked or chipped glass at the neck of Sterile Water for Injection vials.

Pfizer Inc. NDC 50242-901-24 D-1177-2017
Class II · Moderate risk Terminated

Fosphenytoin Sodium Injection

Reason Presence of Particulate Matter

Amneal Pharmaceuticals LLC D-0076-2018
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Noven Pharmaceuticals, Inc. NDC 68968-5553-3 D-1172-2017
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Noven Pharmaceuticals, Inc. NDC 68968-5555-3 D-1171-2017
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Noven Pharmaceuticals, Inc. NDC 68968-5554-3 D-1170-2017
Class II · Moderate risk Terminated

Daytrana

Reason Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Noven Pharmaceuticals, Inc. NDC 68968-5552-3 D-1169-2017
Class II · Moderate risk Terminated

Doctor Manzanilla Cough & Cold

Reason CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Mid Valley Pharmaceutical D-1136-2017
Class II · Moderate risk Terminated

Doctor Manzanilla Allergy & Decongestant Relief

Reason CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Mid Valley Pharmaceutical D-1135-2017